Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.
NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...
The Food and Drug Administration is investigating whether COVID-19 vaccines caused deaths in adults, as part of a safety ...
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...
The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...
A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...
Myocarditis is a known — but small — side effect of the mRNA Covid vaccines from Pfizer and Moderna, information that federal agencies have discussed openly since 2021.
The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...
The U.S. Food and Drug Administration intends to put a "black box" warning on COVID-19 vaccines, CNN reported on Friday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback